Option chain shows key data for Hensoldt's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hensoldt.

Hensoldt (OTC:HAGHY) Stock, Option Chain

Hensoldt AG is engaged in the business of providing defense and security electronics. Its product categories are Radar, IFF and Comms, Optronics, Spectrum Dominance, Avionics, and Integrated Solutions. The company operates in two segments: Sensors and Optronics, of which the majority of its revenue comes from the sensor segment. Its sensor segment provides system solutions and comprises three divisions Radar, Identification Friend or Foe (IFF) and Data Communications (COMMS), Spectrum Dominance and Airborne Solutions, and Customer Services. Its geographical segments are Europe, the Middle East, Asia-Pacific, North America, Africa, LATAM, and other regions.

News

Tech

Media

NNDM

HAGHY

Nano Dimension, Hensoldt Invest $6M In 3D Electronic Printing Joint Venture

Hensoldt AG

Guidance

UPDATE: Canaan Boosts December Mining to 62 BTC, Projects FY25 Revenue Of $900M-$1.1B

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) with a Buy and maintains $44 price target.

Price Target

Reiteration

Analyst Ratings

SMMT

HC Wainwright & Co. Reiterates Buy on Summit Therapeutics, Maintains $44 Price Target

Mesa Air Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on January 15, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") because the Company failed to timely file its Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (the "Form 10-K") with the Securities and Exchange Commission. The filing delay is not the result of a forthcoming restatement of the Company's financial statements or any disagreement with the Company's auditors.

MESA

Mesa Air Group Receives Non Compliance Notice From Nasdaq

Morgan Stanley analyst John Glass maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Equal-Weight and lowers the price target from $53 to $45.

JACK

Morgan Stanley Maintains Equal-Weight on Jack In The Box, Lowers Price Target to $45

Existing mining operations, constituting the first 400 MW Phase I development at the Corsicana Facility and Riot's Rockdale and Kentucky Facilities – as well as associated expansion plans at these locations – remain in place.
As a result of this action, Riot is reducing its previously announced total self-mining hash rate capacity growth and associated capital expenditures for 2025 and will provide additional updates as this review process progresses further.
&nbsp;

RIOT

Riot Platforms Halts Previously Announced Phase II Bitcoin Mining Expansion At Corsicana Facility; Now Projects Capital Expenditures At The Facility In 2025 To Be Reduced By $245M

Posters include real-world dosing of Tyvaso DPI&#xAE; in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, and data from the BREEZE open-label extension study of Tyvaso DPI detailing its long-term outcomes and dosing in patients with pulmonary arterial hypertension&nbsp;
United Therapeutics is sponsoring the Women in PH Luncheon and the Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its commercial and development portfolio in pulmonary hypertension (PH) will be presented at the Pulmonary Vascular Research Institute (PVRI) 2025 Annual Congress taking place January 29 through February 1, 2025 in Rio de Janeiro. In addition, professionals from United Therapeutics will participate in two speaking events associated with the congress.
United Therapeutics is also proud to sponsor the Women in PH Luncheon and the Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals.

Biotech

General

UTHR

United Therapeutics To Present Clinical Data Across Its Commercial And Development Portfolio At The Pulmonary Vascular Research Institute 2025 Annual Congress

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Citigroup analyst Jason Gursky upgraded the rating for Northrop Grumman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) from Neutral to Buy and maintained the price target of $587. Northrop Grumman shares closed at $482.38 on Friday. <a href="https://www.benzinga.com/quote/noc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Benjamin Theurer upgraded FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Equal-Weight to Overweight and maintained the price target of $65. FMC shares closed at $53.43 on Friday. <a href="https://www.benzinga.com/quote/fmc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Durgesh Chopra upgraded the rating for NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) from In-Line to Outperform and raised the price target from $74 to $126. NRG Energy shares closed at $104.51 on Friday. <a href="https://www.benzinga.com/quote/nrg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Simeon Gutman upgraded Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Equal-Weight to Overweight and raised the price target from $430 to $500. Ulta Beauty shares closed at $405.01 on Friday. <a href="https://www.benzinga.com/quote/ulta/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Surinder Thind upgraded the rating for Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) from Hold to Buy and raised the price target from $44 to $55. Genpact shares closed at $45.11 on Friday. <a href="https://www.benzinga.com/quote/G/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png" alt="" class="wp-image-742314" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134.png 1087w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43091705/top-4-health-care-stocks-you-may-want-to-dump-in-q1">Top 4 Health Care Stocks You May Want To Dump In Q1</a></li>
</ul>

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

ULTA

This Ulta Beauty Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Needham analyst Laura Martin reiterates Outbrain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) with a Buy and maintains $9 price target.

Needham Reiterates Buy on Outbrain, Maintains $9 Price Target

Wells Fargo analyst Michael Berg downgrades Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) from Equal-Weight to Underweight and lowers the price target from $16 to $13.

Downgrades

FRSH

Wells Fargo Downgrades Freshworks to Underweight, Lowers Price Target to $13

Riot Platforms Seeks Expert Consultants To Assess AI/HPC Opportunities; Plans To Accelerate Engagement With Potential AI/HPC Partners

Morgan Stanley analyst John Glass maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and lowers the price target from $340 to $336.

Morgan Stanley Maintains Overweight on McDonald's, Lowers Price Target to $336

Southern States (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSBK#NASDAQ">SSBK</a>) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.00 by 4 percent. This is a 28.4 percent increase over earnings of $0.81 per share from the same period last year.

Earnings

Earnings Beats

SSBK

Southern States Q4 Adj $1.04 Beats $1.00 Estimate

WIIM

Tempus AI shares are trading higher after Nancy Pelosi disclosed the purchase of 50 Jan 2026 call options.

HC Wainwright &amp; Co. analyst Kevin Dede reiterates WonderFi Techs (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WNDR#TSX">WNDR</a>) with a Buy and maintains C$0.5 price target.

TSX:WNDR

HC Wainwright & Co. Reiterates Buy on WonderFi Techs, Maintains C$0.5 Price Target

Offerings

PAR Technology Announces Launch Of $100M Offering

Morgan Stanley analyst Brian Harbour maintains US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) with a Overweight and raises the price target from $76 to $82.

USFD

Morgan Stanley Maintains Overweight on US Foods Hldg, Raises Price Target to $82

New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) ("NEH," "New Era Helium" or the "Company"), an exploration and production (E&amp;P) company sourcing helium produced in association with natural gas reserves within the Permian Basin, is pleased to announce the finalization of its previously announced 50/50 joint venture ("JV") with Sharon AI, Inc. ("Sharon AI"), a High-Performance Computing business specializing in Artificial Intelligence, Cloud GPU Compute Infrastructure, and Cloud Storage. The newly created joint venture, named Texas Critical Data Centers ("TCDC"), LLC will be a collaboration to fund, develop, and construct a cutting-edge 250MW net-zero energy data center within the Permian Basin.

Contracts

NEHC

New Era Helium And Sharon AI Finalize 50/50 JV To Develop 250MW Net-Zero Energy Data Center In Permian Basin; Site Selection Expected Q1 2025; 20-Year Gas Supply Negotiation Underway; No Financial Terms Disclosed

UBS analyst Priya Sachdeva initiates coverage on Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Buy rating and announces Price Target of $305.

Initiation

UBS Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $305

Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) shares are trading higher premarket on Tuesday. On Monday, the company inked a deal to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener">acquire </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener">Edge Autonomy</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43086701/redwire-announces-acquisition-of-edge-autonomy-transformational-transaction-creates-a-multi-domain" rel="noreferrer noopener"> for $925 million</a>.
Formed in 2021 through the merger of UAV Factory and Jennings Aeronautics, Edge Autonomy provides field-proven uncrewed airborne system technology.
The transaction includes $150 million in cash and $775 million in Redwire common stock, based on a 30-day volume-weighted average trading price&nbsp;of $15.07.
Redwire may finance the cash portion using its balance sheet, existing credit facility, or new committed debt facilities, leveraging the expected boost in Adjusted EBITDA and free cash flow.
The company also has the option to raise funds through a new equity issuance, with the issuance price adjusting based on the per-share price of the offering.
The acquisition of Edge Autonomy&#8217;s UAS technology expands Redwire&#8217;s multi-domain coverage, creating integrated solutions that enhance connectivity between space and airborne operations.
The transaction is expected to close in the second quarter of 2025, subject to customary approvals and closing conditions.
Post transaction closure, Edge Autonomy and its subsidiaries will become wholly owned by Redwire.
At closing, Redwire will amend its Investor Rights Agreement with AEI, Genesis Park Holdings, and Edge Autonomy Ultimate Holdings.
AEI can appoint four directors to Redwire&#8217;s Board, reducing if its ownership drops below 50%. Seller can appoint one director as long as it holds at least 25% of its shares.
The agreement also includes a six-month lock-up on share sales for AEI and Seller, with some exceptions.
The deal is expected to be immediately accretive to revenue, Adjusted EBITDA, and Free Cash Flow.
For 2025, the combined company forecasts revenue of $535 million – $605 million and Adjusted EBITDA of $70 million – $105 million, with positive Free Cash Flow, assuming the transaction <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">closed on January 1, 2025</a>.
As of September 30, 2024, the company had $43.09 million <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41790012/redwire-corporation-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">in cash and equivalents</a>.
Last week, Redwire disclosed the successful delivery of the fourth pair of Roll-Out Solar Array wings for the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42941879/redwire-successfully-delivers-fourth-pair-of-roll-out-solar-array-wings-for-iss-power" rel="noreferrer noopener">International Space Station</a>.
Price Action: RDW shares are up 11.1% at $16.40 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/content/42971000/these-3-space-stocks-soared-in-2024-can-the-momentum-last" target="_blank" rel="noreferrer noopener">These 3 Space Stocks Soared in 2024: Can the Momentum Last?</a></li>
</ul>
Photo via Shutterstock.

Equities

Small Cap

Movers

Redwire Rockets Forward With $925M Edge Autonomy Acquisition

Morgan Stanley analyst John Glass maintains Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) with a Equal-Weight and lowers the price target from $81 to $73.

Comments

Hensoldt

Hensoldt (HAGHY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga